Pharmaceutical CEO Leadership: Collaboration in Pharma – Choosing Partners
In this segment, members of the Pharmaceutical CEO Leadership: Collaboration in Pharma panel share what to look for in a collaborative partner and the benefit of entering into win-win situations. They also promote the potential of looking toward more unconventional types of partners and reveal what it takes to maintain successful relationships.
Read the full article "Capitalizing on Collaboration."
Expanding Immune Response Testing to Support Vaccine Development
April 22nd 2025Nigel McCracken, chief operating officer, Virax Biolabs, discusses the expansion of its ViraxImmune platform into areas such as transplant monitoring, vaccine efficacy, latent virus reactivation, and CAR T cell therapy.
New Insights Into T Cell Exhaustion and Inflammation in Long COVID
April 17th 2025Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and evidence of T cell exhaustion in long COVID patients, providing deeper insight into post-infection immune disruption.
